ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Swiss Report On Radiotherapy Mortality Questioned

January 7, 1977

NCI Cooperative Group Clinical Trials Approved

April 30, 2010

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

October 22, 1982

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004